2021
DOI: 10.1016/j.medj.2020.12.013
|View full text |Cite
|
Sign up to set email alerts
|

Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
22
0
2

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 24 publications
(26 citation statements)
references
References 33 publications
2
22
0
2
Order By: Relevance
“…The inflammatory response can stimulate the production of inflammatory cells and accelerate the apoptosis of lymphocytes (20). COVID-19 Patients with lymphopenia experience a significantly lower risk of death (21).The neutrophil to lymphocyte ratio is an independent risk factor for the death of COVID-19 patients at hospitals (22).Therefore, the inflammatory parameters in the early stages of the disease should be carefully attended. The number of white blood cellscould be quickly revealedby a routine inpatient blood test, which greatly helpsto identify high-risk COVID-19 patients in the early stages.…”
Section: Resultsmentioning
confidence: 99%
“…The inflammatory response can stimulate the production of inflammatory cells and accelerate the apoptosis of lymphocytes (20). COVID-19 Patients with lymphopenia experience a significantly lower risk of death (21).The neutrophil to lymphocyte ratio is an independent risk factor for the death of COVID-19 patients at hospitals (22).Therefore, the inflammatory parameters in the early stages of the disease should be carefully attended. The number of white blood cellscould be quickly revealedby a routine inpatient blood test, which greatly helpsto identify high-risk COVID-19 patients in the early stages.…”
Section: Resultsmentioning
confidence: 99%
“…However, weighing each of these findings separately as a better predictor of the disease outcome proves to be very complicated. In this context, different scores that group several of these variables and assign a weight to them have emerged continuously up to the present time [ 25 , 26 , 27 ] as well as alternatives to conventional diagnostic tests, such as lung ultrasound [ 28 ]. However, a new question arises when trying to use these indices in clinical practice, where effectiveness in the management of time and resources is essential in a pandemic context.…”
Section: Discussionmentioning
confidence: 99%
“…Os neutrófilos apresentam-se aumentados em pacientes com COVID-19 em relação aos pacientes sem a doença (ESLAMIJOUYBARI et al, 2020;SAYED et al, 2021). Em 11 estudos de 12 que compararam pacientes graves com casos leves, observou que indivíduos com casos graves de COVID-19 tiveram um aumento nos níveis de neutrófilos em relação a casos leves (BELLAN et al, 2021;GALLAND et al, 2021;GEROTZIAFAS et al, 2020;KILERCIK et al, 2021;LANINI et al, 2020;LINSSEN et al, 2020;ZHANG et al, 2020;LIU et al, 2021;OZBALAK et al, 2021;PAKOS et al, 2020;SAYAH et al, 2021).…”
Section: Leucogramaunclassified
“…As plaquetas apresentaram resultados significativos com níveis mais baixos de pacientes com COVID-19 em relação aos pacientes sem a doença (ESLAMIJOUYBARI et al, 2020;SAYED et al, 2021;SEYIT et al, 2021). Em todos os estudos analisados (n= 6) que compararam pacientes graves com casos leves, observou que indivíduos com casos graves de COVID-19 tiveram uma diminuição nos níveis de plaquetas em relação a casos leves (BELLAN et al, 2021;FOY et al, 2020;LANINI et al, 2020;LIU et al, 2021;PAKOS et al, 2020;RAHMAN et al, 2021). O mecanismo para trombocitopenia é multifatorial em casos respiratórios agudos graves e refere-se a uma combinação de infecção viral e ventilação mecânica levando a dano endotelial desencadeando ativação, agregação e trombose plaquetária no pulmão, causando grande consumo de plaquetas (ESLAMIJOUYBARI et al, 2020).…”
Section: Plaquetogramaunclassified